{
    "organizations": [],
    "uuid": "ebfa0580f78d191e881251bb3865f1fcf0847629",
    "author": "",
    "url": "https://www.reuters.com/article/brief-rexahn-pharma-receives-notice-of-a/brief-rexahn-pharma-receives-notice-of-allowance-for-new-u-s-patent-idUSFWN1PO0XE",
    "ord_in_thread": 0,
    "title": "BRIEF-Rexahn Pharma Receives Notice Of Allowance For New U.S. Patent",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 16 PM / in 12 minutes BRIEF-Rexahn Pharma Receives Notice Of Allowance For New U.S. Patent Reuters Staff 1 Min Read \nJan 29 (Reuters) - Rexahn Pharmaceuticals Inc: \n* REXAHN PHARMACEUTICALS RECEIVES NOTICE OF ALLOWANCE FOR A NEW U.S. PATENT COVERING THE USE OF RX-5902 (SUPINOXINâ„¢)  ",
    "published": "2018-01-29T15:15:00.000+02:00",
    "crawled": "2018-01-29T15:33:14.012+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "minute",
        "pharma",
        "receives",
        "notice",
        "allowance",
        "new",
        "patent",
        "reuters",
        "staff",
        "min",
        "read",
        "jan",
        "reuters",
        "rexahn",
        "pharmaceutical",
        "inc",
        "rexahn",
        "pharmaceutical",
        "receives",
        "notice",
        "allowance",
        "new",
        "patent",
        "covering",
        "use"
    ]
}